Search Results - "Postuma, R."

High burden of neurological disease in the older general population: results from the Canadian Longitudinal Study on Aging.

Authors: Wolfson, C. Fereshtehnejad, S.‐M. Pasquet, R. et al.

Source: European Journal of Neurology. Feb2019, Vol. 26 Issue 2, p356-362. 7p. 4 Charts.

Subjects: Parkinson's disease, Neurological disorders, Medical care, Disease prevalence, Neurology

How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.

Authors: Postuma, R. B. Lang, A. E. Gagnon, J. F. et al.

Source: Brain: A Journal of Neurology; Jun2012, Vol. 135 Issue 6, p1860-1870, 11p

Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.

Authors: Postuma, R. B. Gagnon, J. F. Vendette, M. et al.

Source: Brain: A Journal of Neurology; Dec2009, Vol. 132 Issue 12, p3298-3307, 10p, 3 Charts, 2 Graphs

Brain-clinical perfusion patterns may predict conversion subtype in REM sleep behavior disorder.

Authors: Rahayel, S. Postuma, R. Baril, A.-A. et al.

Source: Sleep Medicine. 2022 Supplement 1, Vol. 100, pS225-S225. 1p.

Cognition and olfaction in Parkinson's disease.

Authors: Postuma R Gagnon JF

Source: Brain: A Journal of Neurology; Dec2010, Vol. 133 Issue 12, pe160-e160, 1p

O.016 REM sleep behavior disorder: can you predict Parkinson's in your dreams?

Authors: Postuma, R.

Source: Parkinsonism & Related Disorders. Dec2009 Supplement 2, Vol. 15, pS5-S5. 1p.

Trial of Prasinezumab in Early-Stage Parkinson's Disease.

Authors: Pagano, G. Taylor, K. I. Anzures-Cabrera, J. et al.

Source: New England Journal of Medicine. 8/4/2022, Vol. 387 Issue 5, p421-432. 12p.

Trial of Cinpanemab in Early Parkinson's Disease.

Authors: Lang, A. E. Siderowf, A. D. Macklin, E. A. et al.

Source: New England Journal of Medicine. 8/4/2022, Vol. 387 Issue 5, p408-420. 13p.

Pyridostigmine in the Management of Orthostatic Hypotension: A Systematic Review and Meta-Analysis.

Authors: Pavic, N. Zhang, S. Maloof, A. et al.

Source: Heart, Lung & Circulation. 2025 Supplement 4, Vol. 34, pS600-S600. 1p.

Predicting Time-to-Phenoconversion to Parkinson's Disease/Dementia with Lewy Bodies in Idiopathic REM Sleep Behavior Disorder (iRBD) Using Machine Learning.

Authors: Fereshtehnejad, S.M. Bahador, N. Delva, A. et al.

Source: Parkinsonism & Related Disorders. May2025, Vol. 134, pN.PAG-N.PAG. 1p.

The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies.

Authors: Ruskey, J. A. Zhou, S. Santiago, R. et al.

Source: Clinical Genetics. Oct2018, Vol. 94 Issue 3/4, p339-345. 7p. 2 Diagrams, 4 Charts, 1 Graph.

Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.

Authors: Chahine, L.M. Xie, S.X. Simuni, T. et al.

Source: Parkinsonism & Related Disorders. Jun2016, Vol. 27, p102-106. 5p.

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

Authors: Schenck, C.H. Montplaisir, J.Y. Frauscher, B. et al.

Source: Sleep Medicine. Aug2013, Vol. 14 Issue 8, p795-806. 12p.

Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease - A randomized study.

Authors: Rios Romenets, S Creti, L Fichten, C et al.

Source: Parkinsonism & Related Disorders. Jul2013, Vol. 19 Issue 7, p670-675. 6p.

Brain atrophy in REM sleep behavior disorder is shaped by gene expression and structural connectivity.

Authors: Rahayel, S. Tremblay, C. Vo, A. et al.

Source: Sleep Medicine. 2022 Supplement 1, Vol. 100, pS224-S224. 1p.

Is trauma-associated sleep disorder a sub-form REM sleep behavior disorder? a Canadian longitudinal study on aging cohort study.

Authors: Yao, C. Wolfson, C. Pelletier, A. et al.

Source: Sleep Medicine. Dec2019 Supplement 1, Vol. 64, pS431-S431. 1p.

The impact of subjective excessive daytime sleepiness on cognition in parkinson disease.

Authors: Rosinvil, T. Bellavance, A. Constantin, I. et al.

Source: Sleep Medicine. Dec2019 Supplement 1, Vol. 64, pS327-S327. 1p.

Prevalence and associated factors for REM sleep behaviour disorder: a nation-wide population-based study of 30,097 Canadian adults.

Authors: Yao, C. Fereshtehnejad, S.-M. Keezer, M. et al.

Source: Sleep Medicine. Dec2017 Supplement 1, Vol. 40, pe354-e354. 1p.

Myoclonus as an acute complication of low-dose hydromorphone in multiple system atrophy.

Authors: Hofmann, A. Tangri, N. Lafontaine, A.-L. et al.

Source: Journal of Neurology, Neurosurgery & Psychiatry. Aug2006, Vol. 77 Issue 8, p994-995. 2p.

Corrigendum to “Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group” [Sleep Med 14(8) (2013) 795–806].

Authors: Schenck, C.H. Montplaisir, J.Y. Frauscher, B. et al.

Source: Sleep Medicine. Jan2014, Vol. 15 Issue 1, p157-157. 1p.